Statement of Principles concerning myocarditis (Reasonable Hypothesis) (No. 17 of 2024)

Administered by Department of Veterans' Affairs

Legislation au F2024L00213 In force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

STATEMENT OF PRINCIPLES CONCERNING

MYOCARDITIS

(REASONABLE HYPOTHESIS) (NO. 17 OF 2024)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Statement of Principles concerning myocarditis (Reasonable Hypothesis) (No. 17 of 2024).

Background

2.             The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(2) of the Veterans' Entitlements Act 1986 (the VEA), Statement of Principles concerning myocarditis (Reasonable Hypothesis) (No. 17 of 2024).

3.             The Authority is of the view that there is sound medical-scientific evidence that indicates that myocarditis and death from myocarditis can be related to particular kinds of service.  The Authority has therefore determined this Statement of Principles concerning myocarditis pursuant to subsection 196B(2) of the VEA.

Purpose and Operation

4.             The Statement of Principles will be applied in determining claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

5.             The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

before it can be said that a reasonable hypothesis has been raised connecting myocarditis or death from myocarditis, with the circumstances of that service.  The Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

6.             The Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans' Review Board or Administrative Appeals Tribunal cannot accept any claim for pension; or a claim for liability or compensation relating to myocarditis or death from myocarditis that was lodged on or after 1 June 1994 in the case of the VEA, or 1 July 2004 in the case of the MRCA respectively, unless this Statement of Principles upholds that claim (subsection 120A(3) of the VEA or subsection 338(3) of the MRCA).

7.             This new Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 3 July 2023 concerning myocarditis in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence available to the Authority.

Consultation

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to myocarditis in the Government Notices Gazette of 3 July 2023, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority in relation to the investigation.

Human Rights

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

10.         The determining of this new Instrument finalises the investigation in relation to myocarditis as advertised in the Government Notices Gazette of 3 July 2023.

References

11.         A list of references relating to the above condition is available on the Authority's website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 17 of 2024

Kind of Injury, Disease or Death: Myocarditis

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(2) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have myocarditis;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal; and
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting myocarditis with the circumstances of eligible service rendered by a person, as set out in clause 5 of the Explanatory Statement.

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICESCR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICESCR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Statement of Principles concerning myocarditis (Reasonable Hypothesis) (No. 17 of 2024) was determined by the Repatriation Medical Authority under subsection 196B(2) of the Veterans' Entitlements Act 1986 (VEA). This instrument aims to address the problem of establishing a reasonable hypothesis that connects myocarditis or death from myocarditis with particular kinds of service rendered by veterans and service personnel. The Authority determined this Statement of Principles after reviewing sound medical-scientific evidence that links myocarditis to specific types of service. The Statement of Principles will be applied in assessing claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA), specifying the factors that must exist to connect myocarditis with the service conditions. It ensures that claims made after certain dates cannot be accepted unless they align with this Statement of Principles. This legislative instrument promotes human rights by facilitating the assessment and determination of benefits, ensuring they are reasonable, proportionate, and transparent.

Scope and Application

The Statement of Principles concerning myocarditis (Reasonable Hypothesis) (No. 17 of 2024) applies to veterans and members of the Defence Force who have served under specified conditions, as outlined in the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This Statement of Principles sets forth the factors necessary to establish a reasonable hypothesis connecting myocarditis or death from myocarditis with particular kinds of service, including operational, peacekeeping, hazardous, British nuclear test defence service, warlike, and non-warlike service. The determination of these factors is pivotal for claims related to myocarditis or death from myocarditis lodged on or after 1 June 1994 under the VEA and 1 July 2004 under the MRCA, as no such claims will be accepted without the support of this Statement of Principles. The Repatriation Medical Authority, which established this Statement of Principles, ensures that its provisions are compatible with human rights, thereby facilitating the assessment and determination of claims while upholding veterans' rights to social security, adequate living standards, and health benefits. The application of this Statement of Principles is limited to claims filed after the specified dates under the relevant Acts and does not extend to claims or services prior to these dates. The instrument aims to enhance the medico-scientific quality of outcomes under the VEA and the MRCA by clarifying the requisite conditions for linking myocarditis to service, thereby improving the process for assessing and determining veterans' claims. The Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans' Review Board, and Administrative Appeals Tribunal all adhere to this Statement of Principles in their respective functions. The instrument does not introduce any exclusions or exemptions but rather establishes a framework within which claims must be assessed.

Key Provisions

The Statement of Principles concerning myocarditis (Reasonable Hypothesis) (No. 17 of 2024) primarily sets out the minimum factors that must exist to establish a reasonable hypothesis linking myocarditis or death from myocarditis to particular kinds of service rendered by a person (section 5). This document is crucial for claims under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). The Repatriation Medical Authority (the Authority) determined these principles based on sound medical-scientific evidence, and they will be applied when assessing claims for pension, liability, or compensation related to myocarditis or death from myocarditis that were lodged after specific dates (subsections 120A(3) of the VEA and 338(3) of the MRCA). The Statement of Principles outlines the specific circumstances that must be present to connect myocarditis or death from myocarditis to certain types of service, including operational, peacekeeping, hazardous, and British nuclear test defence service under the VEA, as well as warlike and non-warlike service under the MRCA (section 5). It establishes that these conditions must be related to the service in question for a reasonable hypothesis to be considered valid. This provision ensures that claims are assessed fairly and based on credible medical evidence. Failure to adhere to the requirements outlined in the Statement of Principles can result in the rejection of claims for pension, liability, or compensation related to myocarditis or death from myocarditis that were lodged after the specified dates (subsections 120A(3) of the VEA and 338(3) of the MRCA). There are no specific penalties mentioned in the explanatory statement for breaches of these provisions; however, the implications of not following the principles could lead to the denial of benefits that eligible claimants are entitled to under the VEA and the MRCA. The Statement of Principles has been determined to be compatible with human rights and does not derogate from any human rights (section 9). Instead, it promotes the human rights of veterans, current and former Defence Force members, and their dependents by facilitating the assessment and determination of social security benefits, ensuring access to treatment and rehabilitation, and guaranteeing that these rights are exercised without discrimination. This compatibility with human rights underscores the importance of the principles in providing fair and just outcomes for those who have served in the Defence Force.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Explanatory Statement
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Human Rights Law
Consultation Requirements

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.